By a GenomeWeb staff reporter
NEW YORK (Genomeweb News) – Fluxion Biosciences today has denied that it is infringing patents held by Cellectricon that are at the center of an IP infringement suit that initially began in July 2009 but resumed this week.
Already have a GenomeWeb or 360Dx account?Login Now.
360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.
The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.
In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.
Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.
Proximity ligation technology generates multi-dimensional next-generation sequencing data that is proving to solve unmet needs in genomic research.
This webinar will discuss how an algorithm-driven synthetic biology system can enable engineering of biological systems for a range of applications.